SXTP
60 Degrees Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.92
−1.16%1
Insider buys (3m)
0
Insider sells (3m)
$10.1K
Net value (3m)
-34.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 15, 2026 | DOW GEOFFREY S · director, officer: President and CEO | Purchase | 7,350 | $1.38 |
| Dec 16, 2025 | DOW GEOFFREY S · director, officer: President and CEO | Purchase | 9,670 | $0.80 |
| Dec 12, 2025 | DOW GEOFFREY S · director, officer: President and CEO | Purchase | 9,350 | $0.95 |
| Dec 12, 2025 | DOW GEOFFREY S · director, officer: President and CEO | Purchase | 3,613 | $0.92 |
| Sep 15, 2025 | DOW GEOFFREY S · director, officer: President and CEO | A-Award | 7,201 | $1.39 |
| Aug 14, 2025 | Landon Kristen · officer: Chief Operating Officer | A-Award | 4,540 | $0.00 |
| Aug 14, 2025 | Landon Kristen · officer: Chief Operating Officer | A-Award | 4,167 | $6.85 |
| Jun 9, 2025 | DOW GEOFFREY S · director, officer: President and CEO | A-Award | 4,376 | $2.99 |
| Jun 5, 2025 | XU CHERYL · director | Purchase | 3,000 | $2.87 |
| Jun 5, 2025 | XU CHERYL · director | Purchase | 2,000 | $2.90 |
| Jan 24, 2025 | MILLER TYRONE · officer: CFO | A-Award | 75,000 | $1.31 |
| Jan 24, 2025 | DOW GEOFFREY S · director, officer: President and CEO | A-Award | 525,000 | $1.31 |
| Jan 21, 2025 | MILLER TYRONE · officer: CFO | A-Award | 11,626 | $0.00 |
| Jan 21, 2025 | DOW GEOFFREY S · director, officer: President and CEO | A-Award | 14,394 | $0.00 |
| Dec 18, 2024 | XU CHERYL · director | Purchase | 1,500 | $1.52 |
| Dec 18, 2024 | XU CHERYL · director | Purchase | 2,500 | $1.80 |
| Dec 18, 2024 | XU CHERYL · director | Purchase | 2,000 | $1.45 |
| Dec 9, 2024 | DOW GEOFFREY S · director, officer: President and CEO | Purchase | 20,579 | $1.20 |
| Dec 9, 2024 | DOW GEOFFREY S · director, officer: President and CEO | Purchase | 17,549 | $1.11 |
| Dec 9, 2024 | DOW GEOFFREY S · director, officer: President and CEO | Purchase | 35,823 | $1.27 |
| Nov 21, 2024 | DOW GEOFFREY S · director, officer: President and CEO | Purchase | 1,000 | $0.92 |
| Nov 21, 2024 | DOW GEOFFREY S · director, officer: President and CEO | Purchase | 3,500 | $0.91 |
| Nov 21, 2024 | DOW GEOFFREY S · director, officer: President and CEO | Purchase | 2,500 | $0.90 |
| Sep 11, 2024 | XU CHERYL · director | Purchase | 5,000 | $1.70 |
Institutional positioning
13F filings over the trailing two quarters
New 5Increased 3Reduced 1Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| KATHMERE CAPITAL MANAGEMENT, LLC | New Position | 144,683 | Apr 28, 2026 |
| UBS GROUP AG | Increased | 31,410 | May 5, 2026 |
| CITADEL ADVISORS LLC | New Position | 22,362 | Sep 2, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 16,295 | May 15, 2026 |
| BARCLAYS PLC | Increased | 1,856 | May 15, 2026 |
| NEWEDGE ADVISORS, LLC | New Position | 50 | Jun 3, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | Reduced | 25 | May 15, 2026 |
| TWIN PEAKS WEALTH ADVISORS, LLC | New Position | 8 | May 8, 2026 |
| CITIGROUP INC | New Position | 1 | May 11, 2026 |
| BARCLAYS PLC | Sold Out | 0 | May 15, 2026 |
| OSAIC HOLDINGS, INC. | Sold Out | 0 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| Kathmere Capital Management, LLC | Sold Out | 0 | Apr 28, 2026 |
| CITIGROUP INC | Sold Out | 0 | May 11, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 15, 2026